P. Solal-Céligny

2.1k total citations · 1 hit paper
14 papers, 1.5k citations indexed

About

P. Solal-Céligny is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, P. Solal-Céligny has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 7 papers in Genetics and 7 papers in Oncology. Recurrent topics in P. Solal-Céligny's work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Viral-associated cancers and disorders (6 papers). P. Solal-Céligny is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Viral-associated cancers and disorders (6 papers). P. Solal-Céligny collaborates with scholars based in France, United Kingdom and United States. P. Solal-Céligny's co-authors include Catherine Sebban, F Reyes, Éric Lepage, Gilles Salles, Franck Morschhauser, Ambro van Hoof, Bertrand Coiffier, Philippe Gaulard, André Bosly and Christophe Fermé and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

P. Solal-Céligny

14 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

2005 1.1k citations Pierre Feugier, Ambro van Hoof et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Solal-Céligny France	8	1.2k	818	539	389	165	14	1.5k
Sophie Lefort France	6	994 0.8×	698 0.9×	352 0.7×	283 0.7×	86 0.5×	10	1.3k
G. Lepeu France	10	1.2k 1.0×	775 0.9×	661 1.2×	297 0.8×	91 0.6×	27	1.7k
Liliana Devizzi Italy	22	1.5k 1.3×	960 1.2×	478 0.9×	456 1.2×	161 1.0×	59	1.9k
C. Portlock United States	21	1.1k 0.9×	732 0.9×	438 0.8×	261 0.7×	114 0.7×	36	1.6k
J. M. Vose United States	15	801 0.7×	596 0.7×	289 0.5×	198 0.5×	150 0.9×	34	1.2k
Annalisa Chiappella Italy	23	1.3k 1.1×	782 1.0×	487 0.9×	506 1.3×	221 1.3×	111	1.7k
Christopher Pocock United Kingdom	23	1.2k 1.0×	809 1.0×	1.1k 2.1×	349 0.9×	83 0.5×	64	2.1k
Jocelyn Maragulia United States	16	993 0.8×	581 0.7×	325 0.6×	465 1.2×	112 0.7×	37	1.3k
Roswitha Forstpointner Germany	15	1.5k 1.2×	1.1k 1.4×	732 1.4×	188 0.5×	166 1.0×	38	1.7k
Maura Brugiatelli Italy	23	1.5k 1.3×	862 1.1×	967 1.8×	377 1.0×	102 0.6×	92	2.0k

Countries citing papers authored by P. Solal-Céligny

Since Specialization

Citations

This map shows the geographic impact of P. Solal-Céligny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Solal-Céligny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Solal-Céligny more than expected).

Fields of papers citing papers by P. Solal-Céligny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Solal-Céligny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Solal-Céligny. The network helps show where P. Solal-Céligny may publish in the future.

Co-authorship network of co-authors of P. Solal-Céligny

This figure shows the co-authorship network connecting the top 25 collaborators of P. Solal-Céligny. A scholar is included among the top collaborators of P. Solal-Céligny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Solal-Céligny. P. Solal-Céligny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Davies, Andrew, Francesco Merli, Biljana Mihaljević, et al.. (2014). Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study. The Lancet Oncology. 15(3). 343–352. 90 indexed citations

Colombat, P, Nicole Brousse, Gilles Salles, et al.. (2012). Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up. Annals of Oncology. 23(9). 2380–2385. 36 indexed citations

Bachy, Emmanuel, P. Brice, Hervé Tilly, et al.. (2008). Long Term Follow-up of the GELF86 French and Belgian Trials: Complete Remission after First Line Treatment with Conventional Chemotherapy in Newly Diagnosed Follicular Lymphoma Patients Correlates with Prolonged Overall Survival Compared with Partial Remission. Blood. 112(11). 2590–2590. 3 indexed citations

Federico, Massimo, Monica Bellei, Barbara Pro, et al.. (2007). Revalidation of FLIPI in patients with follicular lymphoma (FL) registered in the F2 study and treated upfront with immunochemotherapy. Journal of Clinical Oncology. 25(18_suppl). 8008–8008. 6 indexed citations

Feugier, Pierre, Ambro van Hoof, Catherine Sebban, et al.. (2005). Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology. 23(18). 4117–4126. 1075 indexed citations breakdown →

Strauss, Sandra J., Tim Lister, Martin Gramatzki, et al.. (2004). Multi-centre, phase II study of combination antibody therapy with epratuzumab plus rituximab in relapsed/refractory indolent and aggressive NHL: Promising preliminary results. Journal of Clinical Oncology. 22(14_suppl). 6579–6579. 3 indexed citations

Marcus, Robert, Kevin Imrie, Andrew Belch, et al.. (2003). An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma.. Ghent University Academic Bibliography (Ghent University). 34 indexed citations

Coiffier, Bertrand, Olivier Hermine, Corinne Haïoun, et al.. (2001). Rituximab plus CHOP (R-CHOP) in the treatment of elderly patients with diffuse large B-cell lymphoma. An update of the GELA study.. Blood. 98(11). 5 indexed citations

Ganem, G., et al.. (2000). Radiation myositis: The possible role of gemcitabine. Annals of Oncology. 11(12). 1615–1616. 24 indexed citations

10.

Cole, Bernard F., P. Solal-Céligny, Richard D. Gelber, et al.. (1998). Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making.. Journal of Clinical Oncology. 16(7). 2339–2344. 35 indexed citations

11.

Solal-Céligny, P., Pauline Brice, Nicole Brousse, et al.. (1996). Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.. Journal of Clinical Oncology. 14(2). 514–519. 127 indexed citations

12.

Fière, D, Marc Marty, P. Solal-Céligny, et al.. (1989). [Intensive induction and early consolidation of acute lymphoid leukemia in the adult. A pilot study of feasibility and long-term development].. PubMed. 18(5). 221–3. 4 indexed citations

13.

Herrera, Ana Cristina da Silva do Amaral, P. Solal-Céligny, Philippe Gaulard, et al.. (1984). [Primary lymphomas of the digestive tract. Therapeutic results of a series of 35 cases].. PubMed. 8(5). 407–13. 5 indexed citations

14.

Solal-Céligny, P., et al.. (1983). The yellow nail syndrome. Light and electron microscopic aspects of the pleura.. PubMed. 107(4). 183–5. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact